Screener
INmune Bio INMB Q3 2025 earnings
Reported October 30, 2025 · After market close
EPS-$0.24Beat by $0.07
EPS estimate-$0.31
Next report
Oct 29, 2026 (in 2 months)Revenue estimate$1.9M
EPS estimate-$0.15
Versus estimates
Revenue
Diluted EPS
FAQ
- When did INmune Bio report Q3 2025 earnings?
- INmune Bio (INMB) reported Q3 2025 earnings on October 30, 2025 after market close.
- What were INmune Bio's Q3 2025 revenue and EPS?
- INmune Bio reported eps of $-0.24 for Q3 2025.
- Did INmune Bio beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.31 by $0.07.
- How did INmune Bio's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 60.0% from $-0.60.
- Where can I find INmune Bio's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-25-103068) and the 10-Q periodic report (0001213900-25-104141) directly on SEC EDGAR. The filing index links above go to sec.gov.
